4//SEC Filing
VELOCITY PHARMACEUTICAL HOLDINGS LLC 4
Accession 0000899243-20-013395
CIK 0001326190other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:45 PM ET
Size
8.1 KB
Accession
0000899243-20-013395
Insider Transaction Report
Form 4
VELOCITY PHARMACEUTICAL HOLDINGS LLC
10% Owner
Transactions
- Sale
Common Stock
2020-05-14$4.81/sh−169,378$814,708→ 1,717,872 total - Sale
Common Stock
2020-05-15$4.65/sh−30,622$142,392→ 1,687,250 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.65 to $5.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F2]The shares are directly held by Velocity Pharmaceutical Holdings LLC ("VPH"). Velocity Pharma Management, LLC ("VPM") is the manager of VPH. David J. Collier and James F. Watson are the managing members of VPM, and as such may be deemed to hold shared voting and dispositive power over the shares held by VPH. Mr. Collier and Mr. Watson disclaim beneficial ownership of the shares held by VPH except to the extent of their pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001802702
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:45 PM ET
- Size
- 8.1 KB